To examine the cellular effects of PECAM-1 in Ph+ leukemic cells, we next examined the human CML K562 cell line, which expresses endogenous PECAM-1 at a barely detectable level (Fig. 5A). The gene discussed is PECAM1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.